Drug Firm Applies to Import Prescription Meds
Published Date: 12/19/2025
Notice
Summary
Aveva Drug Delivery Systems, Inc. wants to become an official importer of a controlled substance called Thebaine, which is a Schedule II drug. This means they’ll be allowed to bring this drug into the U.S. for medical or research use. People who make or use these drugs can share their thoughts or ask for a hearing by January 20, 2026.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in